Ep. 33: What Does it Mean to be a Reimbursement Professional?

Ep. 32: The Tariff Challenge, Policy Optimism, and The MedTech Conference With Scott Whitaker

EP 31: Haven’t We Heard This Song Before? Major EU Regulatory Changes on the Horizon

BTIG Weighs In on Whether Trump Policies Can Dent MedTech’s Healthy Run

Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan

FDA Inspections Getting Prepped and Avoiding Pitfalls

A VC’s View of the Reimbursement Evolution: An Interview with Mike Carusi

Reimbursement for Breakthrough Devices Still Lags—Need for TCET: An Interview with Josh Makower

Ep. 25: Medtech in China: An Island of Relative Calm in a Sea of Volatility

An Interview With Kevin Fu, The First Device Cyber Czar

The Real World Impact of MDR: How CEOs and Investors are Adapting

Medtech Law & Policy - Clearing Up the Confusion on MDR: Where Do We Go From Here?

What Do the US Midterms Mean for Medtech?

What in the (Medtech) World is Happening?

Tracking the Changing Reimbursement Landscape

Changes in China Present New Opportunities

MDR is Here - Now What Does That Mean?

Sandra Siami on the Promise and Challenges of Real World Evidence

Do We Need an Expedited Medtech Reimbursement Program? An Interview with Mark McClellan

The Medical Imaging Perspective with Patrick Hope